Find a Trial
Trial Summary
Protocol No. | PHO-COG-ADVL18P1 | ||
---|---|---|---|
Status | OPEN TO ACCRUAL | ||
Principal Investigator | Batra, Sandeep | ||
Scope | National | ||
Phase | Phase II | ||
Age Group | Adults and Children | ||
Title | ADVL18P1, AN OPEN-LABEL FEASIBILITY STUDY TO ASSESS THE SAFETY AND PHARMACOKINETICS OF ENASIDENIB IN PEDIATRIC PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (R/R-AML) WITH AN ISOCITRATE DEHYDROGENASE-2 (IDH2) MUTATION. | ||
Applicable Disease Sites | Leukemia, other | ||
Participating Institutions | Indiana University (IU) | ||
Treatment Type | Treatment | ||
Contact | Fernanda C. Rankin, | Phone: Pager: Email: fecarnev@iu.edu |